Cytokine-induced killer (CIK) cells are T lymphocytes expanded ex vivo that are endowed with MHC-independent tumoricidal activity. We have recently demonstrated, in a preclinical setting, that CIK cells are active against autologous bone and soft tissue sarcomas. In particular, CIK cells killed a putative sarcoma stem cell population that may underlie disease relapse and chemoresistance.
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma.
SANGIOLO, Dario;AGLIETTA, Massimo;
2014-01-01
Abstract
Cytokine-induced killer (CIK) cells are T lymphocytes expanded ex vivo that are endowed with MHC-independent tumoricidal activity. We have recently demonstrated, in a preclinical setting, that CIK cells are active against autologous bone and soft tissue sarcomas. In particular, CIK cells killed a putative sarcoma stem cell population that may underlie disease relapse and chemoresistance.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Oncoimmunology 2014_Sangiolo D et al_Activity of cytokine_4aperto.pdf
Open Access dal 02/03/2015
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
108.05 kB
Formato
Adobe PDF
|
108.05 kB | Adobe PDF | Visualizza/Apri |
Oncoimmunology 2014.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
934.18 kB
Formato
Adobe PDF
|
934.18 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.